regional anesthesia ed
TRANSCRIPT
-
8/12/2019 Regional Anesthesia ED
1/31
Regional Anaesthesia&
Temperature ControlAizat
-
8/12/2019 Regional Anesthesia ED
2/31
-
8/12/2019 Regional Anesthesia ED
3/31
Definition
Techniques of abolishing pain using localanaesthetic agents as opposed to generalanaesthesia.
Drugs that produce reversible conduction blockade of impulses along central &peripheral nerves producing ANS, sensoryblockade and skeletal muscle paralysis in thearea innervated by affected nerve
-
8/12/2019 Regional Anesthesia ED
4/31
Types
REGIONALANAESTHESIA
TOPICAL CENTRALNERVE BLOCK
SPINAL
ANAESTHESIA
EPIDURAL
ANAESTHESIA
PERIPHERALNERVE BLOCK
PLEXUS BLOCK SINGLE NERVE
BLOCK
INTRAVENOUSREGIONAL
(BIER BLOCK)
-
8/12/2019 Regional Anesthesia ED
5/31
Aim
Provide anesthesia for a surgical procedure
Provide analgesia pre& post-operatively orduring labour and delivery Diagnosis or therapy for patients with chronic
pain syndromes
-
8/12/2019 Regional Anesthesia ED
6/31
LA agent
Esters Procaine, chloropropaine, tetracaine,amethocaine, cocaine
Amides lignocaine, etidocaine, mepivacaine,bupivacaine,ropivacaine
-
8/12/2019 Regional Anesthesia ED
7/31
-
8/12/2019 Regional Anesthesia ED
8/31
DRUGS Lignocaine (USA Lidocaine)
Presentation Clear aq solution lidocaine HCL Plain 0.5%(local infiltration, IVRA ), 1%, 2%(nerve blocks,
extradural anaesthesia) with adrenaline 1:200 000
Use of adrenaline: Vasoconstiction at site of injection rate of
absorption, systemic toxicity, duration of action Gel 2% with or without chlorhexidine
Clinical : onset in 2-20min; duration 60-120min Recommended max dose 1-3mg/kg (7mg/kg with adrenaline) How to prepare
Lignocaine concn : O.5%: 5mg/ml, 1%: 10mg/ml,2%:20mg/ml
E.g: 70kg 210mg : do not use more than 10ml of 2%lignocaine
C/I : Do not use with adrenaline in end arterial supply (fingers,toes, pinna, penis and nose)
-
8/12/2019 Regional Anesthesia ED
9/31
Bupivacaine Presentation clear colourless, aq solution
(bupivacaine hydrochloride ) Plain (0.25%, 0.5%, 0.75%) With 1:200 000 (5g/ml ) adrenaline Heavy 0.5% with 80mg/ml dextrose ( SG 1.026)
Recommended max dose 2mg/kg (150mg plus up to50mg 2 hourly subsequently)
Clinical- onset within 10-20min, duration of action 4-8hrs. 4X as potent as lidocaine, propensity forcardiotoxicity
-
8/12/2019 Regional Anesthesia ED
10/31
ADVANTAGES
Conscious patients assist in positioning early warning of adverse effects avoid airway manipulation & complications
Good quality block in term of motor and sensory adequate as per surgical requirement surgical / hormonal / psychological stress
Less post operative complications less sedated less nausea / vomiting reduce atelectasis pneumonia reduce risk of dvt
early oral intake
-
8/12/2019 Regional Anesthesia ED
11/31
DISADVANTAGES
Patients anxiety increased sympathetic tone unwanted psychological stress
Technically difficult procedure Co-operation from patients are required Abnormal sensation :
paraesthesia / hyperaesthesia
-
8/12/2019 Regional Anesthesia ED
12/31
COMPLICATIONS
Allergic reaction (rare
-
8/12/2019 Regional Anesthesia ED
13/31
Topical Anesthesia
Application of local anesthetic to mucous membrane- cornea, nasal / oral mucosa
Uses : absorb into dermis and block the nerve end awake oral, nasal intubation, superficial surgical procedure
Advantages : technically easy minimal equipment
Disadvantages : potential for large doses leading to toxicity
-
8/12/2019 Regional Anesthesia ED
14/31
Local/Field Anesthesia
Application of local subcutaneously to anesthetisedistal nerve endings
Uses: Suturing, minor superficial surgery, line placement, more
extensive surgery with sedation Advantages:
minimal equipment, technically easy, rapid onset Disadvantages:
potential for toxicity if large field
-
8/12/2019 Regional Anesthesia ED
15/31
Forehead block
2 nerves from superior orbital marginSupraorbital n: 2.5cm from midlineSupratrochlear n: upper medial corner of orbit
Insert needle from eyebrow midline directlaterally
-
8/12/2019 Regional Anesthesia ED
16/31
Auricular block
Nerve: auriculotemporal, greater auricular and lesseroccipital
-
8/12/2019 Regional Anesthesia ED
17/31
Peripheral Nerve Block Injecting local anesthetic near the course of a named
nerve Uses:
Surgical procedures in the distribution of the blockednerve Advantages:
relatively small dose of local anesthetic to cover large area;rapid onset
Disadvantages: technical complexity, neuropathy
-
8/12/2019 Regional Anesthesia ED
18/31
Wrist block
Median nerve : lies superficially between palmaris longus and FCRUlnar nerve : lies between FCU and ulnar arteryRadial nerve: over radial styloid up to extensor surface
-
8/12/2019 Regional Anesthesia ED
19/31
Digital nerve block
Web space approach. 2 dorsal & 2 palmar. NEVER use adrenaline
-
8/12/2019 Regional Anesthesia ED
20/31
Ankle block
-
8/12/2019 Regional Anesthesia ED
21/31
Saphenous nerve: ant and just above medial malleolusSuperficial peroneal nerve: above the ankle joint from anterior border of tibia to lateralmalleolusDeep peroneal n: above ankle joint between tibialis ant tendon and ext hallucis longusSural n: Lateral to achilles tendon to lateral malleolusTibia n: Medial to achilles tendon to lateral PTA (by palpation)
-
8/12/2019 Regional Anesthesia ED
22/31
Femoral block
Femoral nerve : Lateral to artery under inguinal ligament
-
8/12/2019 Regional Anesthesia ED
23/31
Plexus Blockade Injection of local anesthetic
adjacent to a plexus,e.gcervical, brachial or lumbarplexus
Uses : surgical anesthesia or post-operative analgesia in the
distribution of the plexus Advantages:
large area of anesthesia withrelatively large dose of agent
Disadvantages: technically complex, potential
for toxicity and neuropathy
-
8/12/2019 Regional Anesthesia ED
24/31
Biers block (IVRA) Indication : M&R of forearm # Drugs: 10ml of 1% lignocaine
Dosage :0.4ml/kg(2mg/kg), onset 3mins Technique
V/S monitoring & IV branula on bothhands
Torniquet affevted limb: 50-100mmhgabove SBP
Elevate hand above heart beofretorniquet
Confirm dissappearnace of radial pulsebefore injecting LA
Don t deflate cuff within
-
8/12/2019 Regional Anesthesia ED
25/31
Spinal vs Epidural
SPINAL EPIDURAL
site ofadministration :
subarachnoid space CSF (+)
extra dural space --loss of resistance
technically : easierSpinal needle
LOR
more difficultTuohy needle
CSF fluid
failure rate : low high
-
8/12/2019 Regional Anesthesia ED
26/31
Spinal vs Epidural
SPINAL EPIDURAL
onset : Fast Slow
duration : 2 to 2.5 hours( flexible)
flexible
level : lumbar ; sacral cervical to caudal
volume of LA : small
1.0 to 3.0 mls
large
5.0 to 30 mls
-
8/12/2019 Regional Anesthesia ED
27/31
Temperature control
Hypothalamus is the body thermostat Normal core temp: 37C (if taken internally)
36.8 0.4C (98.2 0.7F) in oral,axilla&rectal Ideal site : Pulmonary artery (gold standard)
Using thermistor cathether Blood mix from skin to viscera
-
8/12/2019 Regional Anesthesia ED
28/31
-
8/12/2019 Regional Anesthesia ED
29/31
-
8/12/2019 Regional Anesthesia ED
30/31
-
8/12/2019 Regional Anesthesia ED
31/31
Take home message
LA produce reversible conduction blockage byinhibiting passage of Na ions through the ionselective NA channel at the nerve membrane.
Lignocaine 1-3mg/kg, 2% = 20mg/ml Serious systemic effect are cardiac arrythmias
and convulsion Identify anatomy first before giving LA Hypothalamus controls the body temp